公开(公告)号：EP3970601A1

公开(公告)日：2022-03-23

申请号：EP21197388.8

申请日：2021-09-17

申请人： Pukyong National University Industry - University Cooperation Foundation ,  Kosin University Industry-Academy Cooperation

发明人： AHN, Yeh-Chan ,  KWON, Daa Young ,  KIM, Yi Keun ,  OAK, Chul Ho ,  YUN, Hang Goo ,  KIM, Sung Won

IPC分类号： A61B1/04 ,  A61B1/303 ,  A61B1/32 ,  A61B1/06 ,  A61B1/07

摘要： Disclosed is a mobile colposcopy device for early diagnosis of cervical cancer, which includes an insertion unit which is inserted into the vagina of a woman, has a penetrating hole formed in one end coming into contact with the uterus, and is provided with a capturing path communicating with the penetrating hole, a capturing unit which is provided in the insertion unit so as to capture the cervix through the capturing path, and a lighting unit which is provided on the capturing path of the insertion unit and irradiates a lighting to the cervix through the penetrating hole. According to the present disclosure, the mobile colposcopy device for early diagnosis of cervical cancer can be simply and easily used so as to perform cervical cancer screening using a mobile colposcopy without environmental constraints including hospitals and allows women to early diagnose cervical cancer.

公开(公告)号：EP4253417A1

公开(公告)日：2023-10-04

申请号：EP21898429.2

申请日：2021-11-09

申请人： Daegu Gyeongbuk Institute Of Science and Technology ,  Kosin University Industry-Academy Cooperation ,  Inje University Industry-Academic Cooperation Foundation

发明人： YEA, Kyung Moo ,  JEONG, Jee-Yeong ,  PARK, Sea Gwang ,  SHIN, Ji Won ,  KIM, Min-Jung

IPC分类号： C07K16/28 ,  A61P7/06 ,  A61K39/00

摘要： The present invention relates to a novel anti-C-MPL antibody and a use thereof, and specifically, to an anti-C-MPL antibody having an effect of increasing platelet production and its number through the maturation of megakaryocytes in the bone marrow, and a use thereof. The novel anti-C-MPL antibody (2R13) of the present invention is a polymer material and has a longer half-life than the conventional therapeutic agents, and it has the advantage of low self-antibody production and low immunogenicity as an antibody agent. In addition, it can be used as a therapeutic agent for thrombocytopenia by increasing the platelet level of patients suffering from chronic or complication-induced immune thrombocytopenia.